Latest filing published 21 May 2026 for AMGEN INC.
Insider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Mary E. Klotman: trading record in brief
This profile gathers the share dealings of Mary E. Klotman in Amgen Inc. Between 31 May 2024 and 19 May 2026, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 21 May 2026, the filings show a share grant in Amgen Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mary E. Klotman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 665 shares0Common StockSEC:0000318154-26-000106:0
- 809 shares0Common StockSEC:0001127602-25-015858:0
- 719 shares0Common StockSEC:0001127602-24-017813:0
3 of 3 declarations
